Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Publications

Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

Blood eosinophil count predicts treatment failure and hospital readmission for COPD.

PMID: 33693048
Journal: ERJ open research
Year: 2020
Reference: ERJ Open Res. 2020 Nov 10;6(4). pii: 00188-2020. doi: 10.1183/23120541.00188-2020. eCollection 2020 Oct.
Impact factor: 0
Publication type: Paper in international publication
Authors: Kerkhof, Marjan, Chaudhry, Isha, Pavord, Ian D, Miravitlles, Marc, Kook Rhee, Chin, Halpin, David M G, Usmani, Omar S, Jones, Rupert, Kocks, Janwillem, Alacqua, Marianna et al.
DOI: 10.1183/23120541.00188-2020

Blood eosinophil count predicts treatment failure and hospital readmission for COPD.

PMID: 33693048
Journal: ERJ open research
Year: 2020
Reference: ERJ Open Res. 2020 Nov 10;6(4). pii: 00188-2020. doi: 10.1183/23120541.00188-2020. eCollection 2020 Oct.
Impact factor:
Publication type: Paper in international publication
Authors: Alacqua, Marianna; Chaudhry, Isha; Halpin, David M G; Jones, Rupert; Kaplan, Alan; Kerkhof, Marjan; Kocks, Janwillem; Kook Rhee, Chin; Miravitlles, Marc; Morris, Tamsin et al.
DOI: 10.1183/23120541.00188-2020

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials.

PMID: 32943047
Journal: RESPIRATORY RESEARCH
Year: 2020
Reference: Respir Res. 2020 Sep 17;21(1):240. doi: 10.1186/s12931-020-01482-1.
Impact factor: 3.924
Publication type: Paper in international publication
Authors: Calverley, Peter M A, Chalmers, James D, Miravitlles, Marc, Xue, Wenqiong, Singh, Dave, Wedzicha, Jadwiga A, Siddiqui, Salman, de la Hoz, Alberto, Magnussen, Helgo et al.
DOI: 10.1186/s12931-020-01482-1

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials.

PMID: 32943047
Journal: RESPIRATORY RESEARCH
Year: 2020
Reference: Respir Res. 2020 Sep 17;21(1):240. doi: 10.1186/s12931-020-01482-1.
Impact factor:
Publication type: Paper in international publication
Authors: Calverley, Peter M A; Chalmers, James D; de la Hoz, Alberto; Magnussen, Helgo; Miravitlles, Marc; Siddiqui, Salman; Singh, Dave; Wedzicha, Jadwiga A; Xue, Wenqiong et al.
DOI: 10.1186/s12931-020-01482-1

Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF.

PMID: 31778751
Journal: JOURNAL OF HEPATOLOGY
Year: 2020
Reference: J Hepatol. 2020 Apr;72(4):688-701. doi: 10.1016/j.jhep.2019.11.009. Epub 2019 Nov 25.
Impact factor: 20.582
Publication type: Paper in international publication
Authors: Saliba, Faouzi, Moreau, Richard, Claria, Joan, Aguilar, Ferran, Fenaille, Francois, Lozano, Juanjo, Junot, Christophe, Colsch, Benoit, Caraceni, Paolo, Trebicka, Jonel et al.
DOI: 10.1016/j.jhep.2019.11.009

Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF.

PMID: 31778751
Journal: JOURNAL OF HEPATOLOGY
Year: 2020
Reference: J Hepatol. 2020 Apr;72(4):688-701. doi: 10.1016/j.jhep.2019.11.009. Epub 2019 Nov 25.
Impact factor:
Publication type: Paper in international publication
Authors: Aguilar, Ferran; Albillos, Agustin; Alessandria, Carlo; Angeli, Paolo; Arroyo, Vicente; Baldasarre, Maurizio; Banares, Rafael; Benten, Daniel; Bernal, William; Bernardi, Mauro et al.
DOI: 10.1016/j.jhep.2019.11.009

Blood-based biomarkers and stem cell therapy in human stroke: a systematic review.

PMID: 32638318
Journal: MOLECULAR BIOLOGY REPORTS
Year: 2020
Reference: Mol Biol Rep. 2020 Aug;47(8):6247-6258. doi: 10.1007/s11033-020-05627-9. Epub 2020 Jul 7.
Impact factor: 1.402
Publication type: Review in international publication
Authors: Pala, Elena, Bustamante, Alejandro, Jolkkonen, Jukka, Hommel, Marc, Rosell, Anna, Montaner, Joan et al.
DOI: 10.1007/s11033-020-05627-9

Blood-based biomarkers and stem cell therapy in human stroke: a systematic review.

PMID: 32638318
Journal: MOLECULAR BIOLOGY REPORTS
Year: 2020
Reference: Mol Biol Rep. 2020 Aug;47(8):6247-6258. doi: 10.1007/s11033-020-05627-9. Epub 2020 Jul 7.
Impact factor:
Publication type: Review in international publication
Authors: Bustamante, Alejandro; Hommel, Marc; Jolkkonen, Jukka; Montaner, Joan; Pala, Elena; Rosell, Anna et al.
DOI: 10.1007/s11033-020-05627-9

Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity.

PMID: 32868394
Journal: Journal for ImmunoTherapy of Cancer
Year: 2020
Reference: J Immunother Cancer. 2020 Aug;8(2). pii: jitc-2020-001419. doi: 10.1136/jitc-2020-001419.
Impact factor: 9.913
Publication type: Paper in international publication
Authors: Zanetti, Samanta Romina, Romecin, Paola Alejandra, Vinyoles, Meritxell, Juan, Manel, Fuster, Jose Luis, Camos, Mireia, Querol, Sergi, Delgado, Mario, Menendez, Pablo et al.
DOI: 10.1136/jitc-2020-001419

Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity.

PMID: 32868394
Journal: Journal for ImmunoTherapy of Cancer
Year: 2020
Reference: J Immunother Cancer. 2020 Aug;8(2). pii: jitc-2020-001419. doi: 10.1136/jitc-2020-001419.
Impact factor:
Publication type: Paper in international publication
Authors: Camos, Mireia; Delgado, Mario; Fuster, Jose Luis; Juan, Manel; Menendez, Pablo; Querol, Sergi; Romecin, Paola Alejandra; Vinyoles, Meritxell; Zanetti, Samanta Romina et al.
DOI: 10.1136/jitc-2020-001419

Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study.

PMID: 32572189
Journal: LEUKEMIA
Year: 2020
Reference: Leukemia. 2020 Aug;34(8):2125-2137. doi: 10.1038/s41375-020-0915-9. Epub 2020 Jun 22.
Impact factor: 8.665
Publication type: Paper in international publication
Authors: Etienne, G, Garcia Gutierrez, V, Guerci-Bresler, A P, Hjorth-Hansen, H, Karsenti, J M, Kelly, K R, Le Coutre, P, Martinez Chamorro, C, Oehler, V G, Orti Pascual, G et al.
DOI: 10.1038/s41375-020-0915-9

Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study.

PMID: 32572189
Journal: LEUKEMIA
Year: 2020
Reference: Leukemia. 2020 Aug;34(8):2125-2137. doi: 10.1038/s41375-020-0915-9. Epub 2020 Jun 22.
Impact factor:
Publication type: Paper in international publication
Authors: Abboud, Camille; Abruzzese, E; Akard, L P; Bardy-Bouxin, Nathalie; Bosi, A; Brummendorf, Tim H; Cervantes, F; Charbonnier, A; Di Raimondo, F; Ernst, Thomas et al.
DOI: 10.1038/s41375-020-0915-9

Both Epimutations and Chromosome Aberrations Affect Multiple Imprinted Loci in Aggressive Wilms Tumors.

PMID: 33217932
Journal: Cancers
Year: 2020
Reference: Cancers (Basel). 2020 Nov 18;12(11). pii: cancers12113411. doi: 10.3390/cancers12113411.
Impact factor:
Publication type: Paper in international publication
Authors: Acurzio, Basilia; Carella, Massimo; Cerrato, Flavia; de Alava, Enrique; Gallego, Soledad; Mora, Jaume; Palumbo, Orazio; Pignata, Laura; Riccio, Andrea; Roma, Josep et al.
DOI: 10.3390/cancers12113411

BRAF-mutant Transcriptional Subtypes Predict Outcome of Combined BRAF, MEK, and EGFR Blockade with Dabrafenib, Trametinib, and Panitumumab in Patients with Colorectal Cancer.

PMID: 32047001
Journal: CLINICAL CANCER RESEARCH
Year: 2020
Reference: Clin Cancer Res. 2020 Jun 1;26(11):2466-2476. doi: 10.1158/1078-0432.CCR-19-3579. Epub 2020 Feb 11.
Impact factor: 10.107
Publication type: Paper in international publication
Authors: Yoshino, Takayuki, Bendell, Johanna C, Hollebecque, Antoine, McRee, Autumn J, Siena, Salvatore, Gordon, Michael S, Tabernero, Josep, Yaeger, Rona, O'Dwyer, Peter J, De Vos, Filip et al.
DOI: 10.1158/1078-0432.CCR-19-3579

BRAF-mutant Transcriptional Subtypes Predict Outcome of Combined BRAF, MEK, and EGFR Blockade with Dabrafenib, Trametinib, and Panitumumab in Patients with Colorectal Cancer.

PMID: 32047001
Journal: CLINICAL CANCER RESEARCH
Year: 2020
Reference: Clin Cancer Res. 2020 Jun 1;26(11):2466-2476. doi: 10.1158/1078-0432.CCR-19-3579. Epub 2020 Feb 11.
Impact factor:
Publication type: Paper in international publication
Authors: Andre, Thierry; Atreya, Chloe E; Bendell, Johanna C; Brase, Jan C; Campbell, Catarina D; Corcoran, Ryan B; De Vos, Filip; Gasal, Eduard; Gordon, Michael S; Hollebecque, Antoine et al.
DOI: 10.1158/1078-0432.CCR-19-3579

Brain paraneoplastic syndromes in a patient with mediastinal ganglioneuroma.

PMID: 32944100
Journal: Radiology case reports
Year: 2020
Reference: Radiol Case Rep. 2020 Sep 2;15(11):2059-2062. doi: 10.1016/j.radcr.2020.08.010. eCollection 2020 Nov.
Impact factor: 0
Publication type: Letter or abstract
Authors: Escudero-Fernandez, Jose Migue, Garcia-Carpintero, Angel Sanchez-Montanez, Delgado-Alvarez, Ignacio, Castellote-Alonso, Amparo, Vazquez-Mendez, Elida Josefa et al.
DOI: 10.1016/j.radcr.2020.08.010

Brain paraneoplastic syndromes in a patient with mediastinal ganglioneuroma.

PMID: 32944100
Journal: Radiology case reports
Year: 2020
Reference: Radiol Case Rep. 2020 Sep 2;15(11):2059-2062. doi: 10.1016/j.radcr.2020.08.010. eCollection 2020 Nov.
Impact factor:
Publication type: Letter or abstract
Authors: Castellote-Alonso, Amparo; Delgado-Alvarez, Ignacio; Escudero-Fernandez, Jose Migue; Garcia-Carpintero, Angel Sanchez-Montanez; Vazquez-Mendez, Elida Josefa et al.
DOI: 10.1016/j.radcr.2020.08.010

Brain Penetration of Lorlatinib: Cumulative Incidences of CNS and Non-CNS Progression with Lorlatinib in Patients with Previously Treated ALK-Positive Non-Small-Cell Lung Cancer.

PMID: 32060867
Journal: Targeted Oncology
Year: 2020
Reference: Target Oncol. 2020 Feb;15(1):55-65. doi: 10.1007/s11523-020-00702-4.
Impact factor: 4.036
Publication type: Paper in international publication
Authors: Bauer, Todd M, Shaw, Alice T, Johnson, Melissa L, Navarro, Alejandro, Gainor, Justin F, Thurm, Holger, Pithavala, Yazdi K, Abbattista, Antonello, Peltz, Gerson, Felip, Enriqueta et al.
DOI: 10.1007/s11523-020-00702-4

Brain Penetration of Lorlatinib: Cumulative Incidences of CNS and Non-CNS Progression with Lorlatinib in Patients with Previously Treated ALK-Positive Non-Small-Cell Lung Cancer.

PMID: 32060867
Journal: Targeted Oncology
Year: 2020
Reference: Target Oncol. 2020 Feb;15(1):55-65. doi: 10.1007/s11523-020-00702-4.
Impact factor:
Publication type: Paper in international publication
Authors: Abbattista, Antonello; Bauer, Todd M; Felip, Enriqueta; Gainor, Justin F; Johnson, Melissa L; Navarro, Alejandro; Peltz, Gerson; Pithavala, Yazdi K; Shaw, Alice T; Thurm, Holger et al.
DOI: 10.1007/s11523-020-00702-4

Brain Tissue Oxygen and Cerebrovascular Reactivity in Traumatic Brain Injury: A Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury Exploratory Analysis of Insult Burden.

PMID: 32253987
Journal: JOURNAL OF NEUROTRAUMA
Year: 2020
Reference: J Neurotrauma. 2020 Sep 1;37(17):1854-1863. doi: 10.1089/neu.2020.7024. Epub 2020 May 4.
Impact factor: 3.793
Publication type: Paper in international publication
Authors: Sahuquillo, Juan, Czeiter, Endre, Czosnyka, Marek, Depreitere, Bart, Ercole, Ari, Frisvold, Shirin, Helbok, Raimund, Jankowski, Stefan, Kondziella, Danile, Koskinen, Lars-Owe et al.
DOI: 10.1089/neu.2020.7024

Brain Tissue Oxygen and Cerebrovascular Reactivity in Traumatic Brain Injury: A Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury Exploratory Analysis of Insult Burden.

PMID: 32253987
Journal: JOURNAL OF NEUROTRAUMA
Year: 2020
Reference: J Neurotrauma. 2020 Sep 1;37(17):1854-1863. doi: 10.1089/neu.2020.7024. Epub 2020 May 4.
Impact factor:
Publication type: Paper in international publication
Authors: Anke, Audny; Beer, Ronny; Bellander, Bo-Michael; Beqiri, Erta; Beqiri, Erta; Buki, Andras; Cabeleira, Manuel; Cabeleira, Manuel; Carbonara, Marco; Chieregato, Arturo et al.
DOI: 10.1089/neu.2020.7024

Brand-Specific Enhanced Safety Surveillance of GSK's Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season.

PMID: 31884676
Journal: DRUG SAFETY
Year: 2020
Reference: Drug Saf. 2020 Mar;43(3):265-279. doi: 10.1007/s40264-019-00893-4.
Impact factor: 3.442
Publication type: Paper in international publication
Authors: Nguyen, Bach-Yen, Damaso, Silvia, Godderis, Lode, Martinez-Gomez, Xavier, Eckermann, Tamara, Loos, Hugo, Salamanca de la Cueva, Ignacio, Shende, Vishvesh, Schmidt, Alexander C, Yeakey, Anne et al.
DOI: 10.1007/s40264-019-00893-4

Brand-Specific Enhanced Safety Surveillance of GSK's Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season.

PMID: 31884676
Journal: DRUG SAFETY
Year: 2020
Reference: Drug Saf. 2020 Mar;43(3):265-279. doi: 10.1007/s40264-019-00893-4.
Impact factor:
Publication type: Paper in international publication
Authors: Damaso, Silvia; Dos Santos, Gael; Eckermann, Tamara; Godderis, Lode; Loos, Hugo; Martinez-Gomez, Xavier; Nguyen, Bach-Yen; Salamanca de la Cueva, Ignacio; Schmidt, Alexander C; Shende, Vishvesh et al.
DOI: 10.1007/s40264-019-00893-4

Break in the Stroke Chain of Survival Due to COVID-19.

PMID: 32466738
Journal: STROKE
Year: 2020
Reference: Stroke. 2020 Aug;51(8):2307-2314. doi: 10.1161/STROKEAHA.120.030106. Epub 2020 May 29.
Impact factor: 7.19
Publication type: Paper in international publication
Authors: Gonzalez, Alejandro, Ruiz-Bayo, Lidia, Sanchez-Miura, Jose Antonio, Escudero-Martinez, Irene, Montaner, Joan, Barragan-Prieto, Ana, Perez-Sanchez, Soledad, Moniche, Francisco et al.
DOI: 10.1161/STROKEAHA.120.030106